期刊文献+
共找到217篇文章
< 1 2 11 >
每页显示 20 50 100
Based on network pharmacology,molecular docking and experimental validation to reveal the potential molecular mechanism of quercetin for the treatment of diarrheal irritable bowel syndrome
1
作者 FENG Min-chao LUO Fang +5 位作者 XIE Sheng CHEN Zu-min TAN Jin-xuan LI Kai CHEN Guo-zhong WANG Dao-gang 《Journal of Hainan Medical University》 CAS 2024年第3期42-52,共11页
Objective:To explore the potential mechanism of action of quercetin in the treatment of diarrhea irritable bowel syndrome(IBS-D).Methods:The potential targets of quercetin were obtained from the TCMSP,SwissTar-getPred... Objective:To explore the potential mechanism of action of quercetin in the treatment of diarrhea irritable bowel syndrome(IBS-D).Methods:The potential targets of quercetin were obtained from the TCMSP,SwissTar-getPrediction,and BATMAN-TCM databases.The targets of IBS-D were obtained by searching the GeneCards database with"diarrhea irritable bowel syndrome"as the keyword,and the targets of quercetin and IBS-D were intersected.The PPI network was constructed by Cytoscape 3.7.1 software.The intersected targets were imported into the DAVID database for GO functional analysis and KEGG pathway enrichment analysis.The binding ability of quercetin to the core targets was observed using molecular docking.Based on this,we established an IBS-D rat model,administered quercetin for intervention,and experimentally validated the network pharmacology prediction results by HE staining and ELISA assay.Results:Network pharmacology analysis showed that TP53,TNF-α,AKT1,VEGF-A,IL-6 factors and MAPK,PI3K-Akt signaling pathway as the core targets and pathways of quercetin for the treatment of IBS-D.The results of animal experiments revealed that quercetin could inhibit the secretion of TP53,TNF-α,AKT1,VEGF-A,IL-1βand IL-6,reduce the inflammatory response and improve IBS-D.Conclusion:Quercetin could protect colon tissue by regulating the expression of TP53,TNF-α,AKT1,VEGF-A,IL-1βand IL-6,thereby treating IBS-D. 展开更多
关键词 QUERCETIN diarrheal irritable bowel syndrome Network pharmacology Molecular docking Inflammatory re-sponse Mechanism of action
下载PDF
Genetic and Antibiotic Resistance Characteristics ofCampylobacterjejuni Isolated from Diarrheal Patients,Poultry and Cattle in Shenzhen 被引量:5
2
作者 JU Chang Yan ZHANG Mao Jun +7 位作者 MA Yan Ping LU Jing Rang YU Mu Hua CHEN Hui LIU Chu Yun GU Yi Xin FU Yan Yan DUAN Yong Xiang 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2018年第8期579-585,共7页
Objective To investigate genetic and antibiotic resistance characteristics of Campylobacter jejuni(C. jejuni) isolated from Shenzhen. Methods Multilocs sequence typing and agar dilution methods were used to define the... Objective To investigate genetic and antibiotic resistance characteristics of Campylobacter jejuni(C. jejuni) isolated from Shenzhen. Methods Multilocs sequence typing and agar dilution methods were used to define the genotype and antibiotic resistance of C. jejuni, respectively. Results In total, 126 C. jejuni strains were isolated. The prevalence of C. jejuni was 5.3% in diarrheal patients. The prevalence in poultry meat(36.5%) was higher than that in cattle meat(1.1%). However, the prevalence in poultry cloacal swabs(27.0%) was lower than that in cattle stool(57.3%). Sixty-two sequence types were obtained, among which 27 of the STs and 10 alleles were previously unreported. The most frequently observed clonal complexes were ST-21(11.9%), ST-22(10.3%), and ST-403(7.1%). ST-21, ST-45, ST-354, ST-403, and ST-443 complexes overlapped between isolates from patients and cattle, whereas ST-45 and ST-574 complexes overlapped between isolates from patients and poultry. All C. jejuni were resistant to at least one antibiotic. The highest resistance rate was toward ciprofloxacin(89.7%), followed by tetracycline(74.6%), and nalidixic acid(69.0%). Conclusion This is the first report of the genotypes and antibiotic resistance of C. jejuni in Shenzhen. Overlapping clonal complexes were found between isolates from patients and cattle, and between patients and poultry. 展开更多
关键词 Campylobacter jejuni Multilocus sequence typing Antibiotic resistance POULTRY CATTLE diarrheal patients
下载PDF
Analgesic,anti-inflammatory and anti-diarrheal activities of ethanolic leaf extract of Typhonium trilobatum L.Schott 被引量:6
3
作者 Khadem Ali Ayesha Ashraf Nripendra Nath Biswas 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2012年第9期722-726,共5页
Objective:To explore the efficacy of ethanolic leaf extract of Typhonium trilobatum L.Schott in treating diarrhea,pain and inflammation using experimental models.Methods:In the present study,acetic acid-induced writhi... Objective:To explore the efficacy of ethanolic leaf extract of Typhonium trilobatum L.Schott in treating diarrhea,pain and inflammation using experimental models.Methods:In the present study,acetic acid-induced writhing,xylene-induced ear edema and castor oil-imluced diarrlieal model were used to evaluate the analgesic,anti-inflammatory and anti-diarrheal activities,respectively.Acute toxicity test was carried out to fix the safe doses of the plant extract.Results:The plant extract demonstrated a significant inhibition of writhing(P<0.01)compared with the control group in acetic acid-induced writhing test in mice.The extract also significantly inhibited the xylene induced ear edema formation(P<0.05).In anti-diarrheal test,the extract significantly decreased the frequency of defecation and increased the mean latent period(P<0.0l)in castor oil-induced diarrheal model mice at the doses of 250 and 500 mg/kg body weight.Conclusions:These results suggest that the extract possesses significant analgesic,anti-inflammatory and anti-diarrheal activities that support to the ethnopharmacologicl uses of this plant. 展开更多
关键词 ANALGESIC ANTI-INFLAMMATORY Anti-diarrheal Typhonium trilobatum TOXICITY
下载PDF
Isolation and Identification of Two Antibacterial Agents from <i>Chromolaena odorata</i>L. Active against Four Diarrheal Strains 被引量:2
4
作者 Ménonvè Atindehou Latifou Lagnika +9 位作者 Bernard Guérold Jean Marc Strub Minjie Zhao Alain Van Dorsselaer Eric Marchioni Gilles Prévost Youssef Haikel Corinne Taddéi Ambaliou Sanni Marie-Hélène Metz-Boutigue 《Advances in Microbiology》 2013年第1期115-121,共7页
Chromolaena odorata L (Asteraceae) is a bad invasive plant, found in the humid tropics and sub-tropics worldwide. It is used against dysentery, diarrhea, malaria, wound healing, headache and toothache in traditional m... Chromolaena odorata L (Asteraceae) is a bad invasive plant, found in the humid tropics and sub-tropics worldwide. It is used against dysentery, diarrhea, malaria, wound healing, headache and toothache in traditional medicine. In the present study, we investigated the antibacterial activities of different leaves extracts of Chromolaena odorata L. (cyclohexane, dichloromethane, ethyl acetate and butanol) against four clinical diarrheal strains (Klebsiella oxytoca, Salmonella enterica, Shigella sonnei and Vibrio cholera). We demonstrated that C. odorata leaves extracts show an antibacterial activity between 0.156 and 1.25 mg/mL. Bioassay-guided chromatography by bioautography with iodonitrotetrazolium-based colorimetric assay allowed the isolation and identification of two active compounds. After the combination of RP-HPLC, mass spectrometry analysis, 1D and 2D-NMR spectroscopy, we isolated and characterized two active molecules corresponding to 3’,4’,5,6,7-Pentamethoxyflavone (Sinensetin) and4’,5,6,7-Tetramethoxyflavone (Scutellareintetramethyl ether). 展开更多
关键词 Chromolaena odorata 3’ 4’ 5 6 7-Pentamethoxyflavone (Sinensetin) 7-Tetramethoxyflavone (Scutellareintetramethyl ether) ANTIBACTERIAL Activity diarrheal STRAINS
下载PDF
The effect of zinc supplementation on diarrheal diseases in children in the Niger Delta Sub-Region of Nigeria
5
作者 Eme Asuquo Udeme Georgewill +3 位作者 Idorenyin Nta Nkechinyere Enyidah Essiet Umofia Suanu Deekae 《Open Journal of Preventive Medicine》 2012年第2期137-140,共4页
This study evaluated the trend of diarrheal diseases managed with zinc supplementation by comparing it with diarrheal diseases managed without zinc supplementation at the University of Port Harcourt Teaching hospital ... This study evaluated the trend of diarrheal diseases managed with zinc supplementation by comparing it with diarrheal diseases managed without zinc supplementation at the University of Port Harcourt Teaching hospital (UPTH), Nigeria. The study was a descriptive retrospective study done at the Diarrhea Training Unit (DTU) of UPTH to determine the effect of zinc supplementation in the management of diarrhea in children under 5 years. Out of the 134 case records studied, of children aged 0 to 59 months who presented with diarrhea at the DTU, 57 children did not receive zinc supplementation between October and December, 2007 and 77 children received zinc supplementation between October and December 2009. The results showed that (74) 96.1% of patients who received zinc supplementation, and (48) 84.2% of those who did not, had no repeat diarrheal episodes when seen at the follow up clinic. On the other hand, 1.3% of those who received zinc supplementation and 1.8% of those who did not, had increased episodes of diarrhea when seen at the follow up clinic. Of those who received, and those who did not receive zinc supplementation, 2.6% and 14% respectively, had reduced episodes of diarrhea. These findings clearly demonstrate the effectiveness of zinc supplementation in halting the course of diarrheal diseases in children aged 0 to 59 months. We therefore advocate for the use of zinc supplementation in the management of diarrhea in 展开更多
关键词 diarrheal DISEASES Zinc Supplementation CHILDREN NIGER DELTA SUB-REGION
下载PDF
Anti-diarrheal and spasmolytic activities study of 3,4-Dihydro-2-(4-Morpholinylmethy)-1(2H)-Naphthalenone(CY)
6
作者 WEI Wei1,FU Shou-ting1,LI Xue1,WEN Min1,HU Chun2(1.Department of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China 2.Department of Organic Chemistry,Shenyang Pharmaceutical University,Shenyang 110016,China) 《沈阳药科大学学报》 CAS CSCD 北大核心 2008年第S1期122-123,共2页
Objective To investigate the spasmolytic and anti-diarrheal activities of 3,4-dihydro-2-(4-morpholinylmethy)-1(2H)-naphthalenone(CY),which was first synthesized by Welch,Willard M et al.in 1977.Methods The spasmolytic... Objective To investigate the spasmolytic and anti-diarrheal activities of 3,4-dihydro-2-(4-morpholinylmethy)-1(2H)-naphthalenone(CY),which was first synthesized by Welch,Willard M et al.in 1977.Methods The spasmolytic effects of CY were tested on isolated rabbit small intestine at the concentration of 0.01 to 3 mM;the diarrheal-index was evaluated on diarrhea mice to study the anti-diarrheal activities of CY.Results CY(0.1-1 mM)inhibited spontaneous motility of rabbit small intestine and at the concentration of 0.01 to 3 mM CY inhibited the contractile response of rabbit small intestine and colon induced by acetylcholine(10-2 mg·mL-1),high K+(60 mM)and BaCl2(1 mg·mL-1).When tested against calcium channel blocked in rabbit small intestine and colon,CY caused a rightward shift in the Ca2+ dose-response curves,similar to that produced by verapamil,a well-known calcium antagonist.CY could inhibit the diarrhea induced by castor oil,MgSO4 and liquid paraffin and LD50 of CY is 277.2 mg·kg-1.Conclusions CY may produce its spasmolytic and anti-diarrheal effects as a calcium antagonist. 展开更多
关键词 CY anti-diarrheal SPASMOLYTIC calcium ANTAGONIST
下载PDF
Accessibility to Safe Drinking Water and Diarrheal Diseases: A Quasi-Experiment on a Case of Water Well Drilling in the Village of Kassouala, Municipality of Tchaourou, Benin, January 2018-July 2019
7
作者 Luc Béhanzin David Houéto +3 位作者 Jeanne Chantal Hounyo Ella Goma-Matsétsé Maurice Agonnoudé Thierry Adoukonou 《Open Journal of Epidemiology》 2022年第2期107-124,共18页
Background: In 2017, 900 million people in the world did not have sustainable access to safe drinking water (SDW). In addition, between 2016 and 2020, the global population with safely managed drinking water at home i... Background: In 2017, 900 million people in the world did not have sustainable access to safe drinking water (SDW). In addition, between 2016 and 2020, the global population with safely managed drinking water at home increased from 70 percent to 74 percent. Drinking water insecurity is the daily situation of people in developing countries. The lack of SDW supply is at the root of many diseases, including diarrheal diseases. Kassouala is a village in the municipality of Tchaourou without access to SDW, but having benefited from the drilling of a well in September 2018. The objective of this study was to study the effect of access to safe drinking water on the frequency of diarrheal diseases in Kassouala between January 2018 and July 2019. Methods: We conducted a quasi-experimental study in Kassouala using the natural experiments of the village of Bérétou as a control group for estimating the effect of a causal nature. There were double temporal (January 2018-July 2019) and geographical (Kassouala-Bérétou) comparisons based on data collected from health care registers. A population-based comparability survey of the two villages was conducted among 170 households in each village (experimental village, control village). A two-stage cluster sampling procedure was used to select the survey participants. Data were collected from heads of household by semi-structured questionnaire. We used Pearson or Mantel-Haenszel chi-square tests, as appropriate, and the “difference-in-difference” method to assess the effect. Results: In Kassouala, the proportion of households with access to safe drinking water had increased to 78.88%, whereas it was nil in 2018 before the well drilling, and the frequency of diarrheal diseases decreased significantly from January 2018 before drilling to July 2019 after drilling (57.11% to 44.64%;p Conclusion: Access to safe drinking water in Kassouala has a causal effect on the reduction of diarrheal diseases. However, for the supply of drinking water to be integrated into the community development plan of Tchaourou, it is necessary to support the scaling up of this intervention, which would be considered as a pilot, of a community participation program. 展开更多
关键词 diarrheal Diseases Water Supply Drinking Water Community Participation BENIN
下载PDF
调神健脾针刺法联合电针治疗腹泻型肠易激综合征的疗效观察及对肥大细胞活化的影响
8
作者 占道伟 刘军 +5 位作者 徐颖梅 洪中华 李玲 沈志炜 罗开涛 孙建华 《上海针灸杂志》 CSCD 2024年第6期594-598,共5页
目的观察调神健脾针刺法联合电针治疗对腹泻型肠易激综合征(irritable bowel syndromediarrheal,IBS-D)的临床疗效及其对患者肠黏膜肥大细胞活化的影响。方法将60例IBS-D患者按随机数字表法分为药物组和观察组,每组30例。药物组予口服... 目的观察调神健脾针刺法联合电针治疗对腹泻型肠易激综合征(irritable bowel syndromediarrheal,IBS-D)的临床疗效及其对患者肠黏膜肥大细胞活化的影响。方法将60例IBS-D患者按随机数字表法分为药物组和观察组,每组30例。药物组予口服马来酸曲美布汀分散片治疗,观察组予调神健脾针刺法联合电针治疗。观察两组治疗前后肠易激综合征症状严重程度量表(irritable bowel syndrome-symptom severity scale,IBS-SSS)评分、肠易激综合征生活质量量表(irritable bowel syndrome-quality of Life,IBS-QOL)评分和医院焦虑抑郁量表(hospital anxiety and depression scale,HADS)评分及肠黏膜肥大细胞(mast cells,MCs)活化程度的变化。比较两组临床疗效。结果观察组总有效率优于药物组(P<0.05)。治疗后,两组IBS-SSS和HADS评分均降低(P<0.05),且观察组均优于药物组(P<0.05)。治疗后,两组IBS-QOL评分均升高(P<0.05),且观察组高于药物组(P<0.05)。治疗后,两组MCs数量与脱颗粒比例均降低(P<0.05),且观察组优于药物组(P<0.05)。结论“调神健脾”针刺法联合电针治疗IBS-D的临床疗效优于单一口服药物治疗,可缓解腹痛等临床症状,提高生活质量,改善抑郁状态,降低MCs活化程度。 展开更多
关键词 针刺疗法 电针 肠易激综合征 腹泻 肥大细胞 胃肠功能紊乱
下载PDF
Epidemiological Surveillance: Genetic Diversity of Rotavirus Group A in the Pearl River Delta, Guangdong, China in 2019
9
作者 JIANG Jie Ying LIANG Dan +9 位作者 WANG Li XIAO Yun LIANG Yu Feng KE Bi Xia SU Juan XIAO Hong WANG Tao ZOU Min LI Hong Jian KE Chang Wen 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2024年第3期278-293,共16页
Objective This study aimed to understand the epidemic status and phylogenetic relationships of rotavirus group A(RVA)in the Pearl River Delta region of Guangdong Province,China.Methods This study included individuals ... Objective This study aimed to understand the epidemic status and phylogenetic relationships of rotavirus group A(RVA)in the Pearl River Delta region of Guangdong Province,China.Methods This study included individuals aged 28 days–85 years.A total of 706 stool samples from patients with acute gastroenteritis collected between January 2019 and January 2020 were analyzed for 17 causative pathogens,including RVA,using a Gastrointestinal Pathogen Panel,followed by genotyping,virus isolation,and complete sequencing to assess the genetic diversity of RVA.Results The overall RVA infection rate was 14.59%(103/706),with an irregular epidemiological pattern.The proportion of co-infection with RVA and other pathogens was 39.81%(41/103).Acute gastroenteritis is highly prevalent in young children aged 0–1 year,and RVA is the key pathogen circulating in patients 6–10 months of age with diarrhea.G9P[8](58.25%,60/103)was found to be the predominant genotype in the RVA strains,and the 41 RVA-positive strains that were successfully sequenced belonged to three different RVA genotypes in the phylogenetic analysis.Recombination analysis showed that gene reassortment events,selection pressure,codon usage bias,gene polymorphism,and post-translational modifications(PTMs)occurred in the G9P[8]and G3P[8]strains.Conclusion This study provides molecular evidence of RVA prevalence in the Pearl River Delta region of China,further enriching the existing information on its genetics and evolutionary characteristics and suggesting the emergence of genetic diversity.Strengthening the surveillance of genotypic changes and gene reassortment in RVA strains is essential for further research and a better understanding of strain variations for further vaccine development. 展开更多
关键词 Infectious diarrheal disease ROTAVIRUS Phylogenetic analysis Gene rearrangement Codon usage bias Genetic diversity
下载PDF
基于网络药理学、分子对接与实验验证揭示槲皮素治疗腹泻型肠易激综合征的潜在分子机制 被引量:1
10
作者 冯敏超 罗芳 +5 位作者 谢胜 陈祖民 谭瑾轩 李凯 陈国忠 王道刚 《海南医学院学报》 CAS 北大核心 2024年第3期203-214,共12页
目的:探索槲皮素治疗腹泻型肠易激综合征(Diarrhoeal irritable bowel syndrome,IBS-D)的潜在作用机制。方法:从TCMSP、SwissTar-getPrediction、BATMAN-TCM数据库获得槲皮素的潜在靶点,以“diarrhea irritable bowel syndrome”作为关... 目的:探索槲皮素治疗腹泻型肠易激综合征(Diarrhoeal irritable bowel syndrome,IBS-D)的潜在作用机制。方法:从TCMSP、SwissTar-getPrediction、BATMAN-TCM数据库获得槲皮素的潜在靶点,以“diarrhea irritable bowel syndrome”作为关键词检索GeneCards数据库,得到IBS-D的相关靶点,将槲皮素与IBS-D的靶点取交集。通过Cytoscape 3.7.1软件构建PPI网络。交集靶点导入DAVID数据库进行GO功能分析和KEGG途径富集分析。利用分子对接观察槲皮素与核心靶点的结合能力;在此基础上,建立IBS-D大鼠模型,给予槲皮素进行干预,通过HE染色、ELISA检测对网络药理学预测结果进行实验验证。结果:网络药理学分析显示,TP53,TNF-α,AKT1,VEGF-A,IL-6因子和MAPK、PI3K-Akt信号通路作为槲皮素治疗IBS-D的核心靶点和通路;动物实验结果发现,槲皮素能抑制TP53,TNF-α,AKT1,VEGF-A,IL-1β和IL-6的分泌,减轻炎症反应,改善IBS-D。结论:槲皮素可能下调TP53,TNF-α,AKT1,VEGF-A,IL-1β和IL-6的表达保护结肠组织,从而治疗IBS-D。 展开更多
关键词 槲皮素 腹泻型肠易激综合征 网络药理学 分子对接 炎症反应 作用机制
下载PDF
理肠丸治疗腹泻型肠易激综合征的疗效观察和对免疫球蛋白及肠道菌群调节的影响
11
作者 神和正 程晓云 +5 位作者 王成宝 于天祥 刘艳 李海燕 刘文通 李琪 《山东医学高等专科学校学报》 2024年第3期23-26,共4页
目的目的探讨IBS-D的治疗方法。方法将100例IBS-D患者随机分为治疗组和对照组,各50例,对照组口服匹维溴铵片,治疗组口服理肠丸。观察治疗前后两组中医证候评分与疗效、IBS-SSS评分与疗效、免疫球蛋白及肠道菌群。结果治疗后,治疗组中医... 目的目的探讨IBS-D的治疗方法。方法将100例IBS-D患者随机分为治疗组和对照组,各50例,对照组口服匹维溴铵片,治疗组口服理肠丸。观察治疗前后两组中医证候评分与疗效、IBS-SSS评分与疗效、免疫球蛋白及肠道菌群。结果治疗后,治疗组中医证候评分与疗效、IBS-SSS评分与疗效、IgA、IgG、肠杆菌、肠球菌、双歧杆菌、乳酸杆菌改善程度均优于对照组(P<0.01)。结论理肠丸治疗IBS-D效果显著。 展开更多
关键词 理肠丸 腹泻型肠易激综合征 免疫球蛋白 肠道菌群
下载PDF
安肠止泻方剂联合针刺治疗腹泻型肠易激综合征模型大鼠对炎症因子的效果
12
作者 赵舒婷 李婷 +3 位作者 宋纪池 朱雨洁 曾叶芝 初晓 《生物化工》 CAS 2024年第1期14-17,共4页
目的:分析安肠止泻方剂联合针刺治疗腹泻型肠易激综合征(IBS-D)模型大鼠对炎症因子的效果。方法:50只SPF级SD大鼠(2周龄)分为健康组(未造模,日常灌胃生理盐水)、模型组(造模成功后不予其他干预,日常灌胃生理盐水)、方剂组(造模成功后予... 目的:分析安肠止泻方剂联合针刺治疗腹泻型肠易激综合征(IBS-D)模型大鼠对炎症因子的效果。方法:50只SPF级SD大鼠(2周龄)分为健康组(未造模,日常灌胃生理盐水)、模型组(造模成功后不予其他干预,日常灌胃生理盐水)、方剂组(造模成功后予以安肠止泻方剂)、针刺组(造模成功后予足三里、关元、内关穴针刺干预)和联合组(联合使用方剂组、针刺组干预方式),干预周期均为14 d。比较各组造模前和造模后(造模14 d)、干预前和干预后(干预14 d)白介素1(IL-1)、白介素6(IL-6)、肿瘤坏死因子α(TNF-α)含量的统计学差异。结果:造模后,模型组IBS-D大鼠IL-1、IL-6、TNF-α含量均高于健康组,差异均有统计学意义(P<0.05)。组内比较发现,方剂组、针刺组、联合组IBS-D大鼠干预后的IL-1、IL-6、TNF-α含量均低于干预前,差异均有统计学意义(P<0.05)。干预后组间比较,除联合组针刺组TNF-α含量、针刺组和方剂组IL-6和TNF-α含量的差异无统计学意义(P>0.05),其余各组IL-1、IL-6、TNF-α含量差异均有统计学意义(P<0.05)。结论:安肠止泻方剂联合针刺干预IBS-D效果优于单种干预措施,能明显控制体内炎症状态。 展开更多
关键词 安肠止泻方剂 针刺 腹泻型肠易激综合征 炎症因子
下载PDF
中医经方治疗腹泻型肠易激综合征的研究进展
13
作者 王姣姣 罗慧君 蔺晓源 《中医药学报》 CAS 2024年第4期112-116,共5页
腹泻型肠易激综合征(IBS-D)是最常见的功能障碍型肠病之一,发病率高,治愈难度大,目前对其研究主要围绕临床和实验两方面。中医经方在IBS-D的治疗中疗效显著,本文整理并总结其疗效及机制的最新进展,为中医药防治IBS-D的临床及基础研究提... 腹泻型肠易激综合征(IBS-D)是最常见的功能障碍型肠病之一,发病率高,治愈难度大,目前对其研究主要围绕临床和实验两方面。中医经方在IBS-D的治疗中疗效显著,本文整理并总结其疗效及机制的最新进展,为中医药防治IBS-D的临床及基础研究提供思路与借鉴。 展开更多
关键词 腹泻型肠易激综合征 中医经方 综述
下载PDF
自拟中药方(健脾温阳止泻汤)治疗腹泻型肠易激综合征的临床疗效分析
14
作者 房贤村 张广林 +2 位作者 刘秋芹 国龙溪 吴华清 《系统医学》 2024年第9期5-8,共4页
目的探讨自拟中药方(健脾温阳止泻汤)治疗腹泻型肠易激综合征的临床效果。方法选取2022年1月—2023年1月寿光市人民医院收治的80例腹泻型肠易激综合征患者为研究对象,经随机数表法分为对照组和治疗组,每组40例。对照组给予口服复方谷氨... 目的探讨自拟中药方(健脾温阳止泻汤)治疗腹泻型肠易激综合征的临床效果。方法选取2022年1月—2023年1月寿光市人民医院收治的80例腹泻型肠易激综合征患者为研究对象,经随机数表法分为对照组和治疗组,每组40例。对照组给予口服复方谷氨酰胺肠溶胶囊的方法进行治疗;治疗组给予自拟健脾温阳止泻汤,比较两组的症状积分及疗效。结果治疗后,治疗组患者的总有效率为95%,对照组患者的治疗总有效率为75%,治疗组的总有效率高于对照组,差异有统计学意义(χ^(2)=6.405,P<0.05);治疗组症状积分低于对照组,差异有统计学意义(P<0.05)。结论健脾温阳止泻汤治疗腹泻型肠易激综合症的效果较为明显,可以改善患者腹胀、腹痛、排便症状。 展开更多
关键词 自拟中药方 健脾温阳止泻汤 腹泻型肠易激综合症 临床疗效
下载PDF
参苓白术散加减对腹泻型肠易激综合征脾虚湿盛证患者血清胃肠激素水平的影响 被引量:1
15
作者 徐博文 徐海丰 程晨 《检验医学与临床》 2024年第4期530-532,537,共4页
目的探讨腹泻型肠易激综合征(IBS-D)脾虚湿盛证患者应用参苓白术散加减治疗的效果。方法选取2020年10月至2022年10月该院收治的78例IBS-D脾虚湿盛证患者为研究对象,按照随机数字表法分为观察组与对照组,各39例。对照组采用匹维溴铵治疗... 目的探讨腹泻型肠易激综合征(IBS-D)脾虚湿盛证患者应用参苓白术散加减治疗的效果。方法选取2020年10月至2022年10月该院收治的78例IBS-D脾虚湿盛证患者为研究对象,按照随机数字表法分为观察组与对照组,各39例。对照组采用匹维溴铵治疗,观察组联合参苓白术散加减治疗,均连续治疗4周。比较两组总有效率、降钙素基因相关肽(CGRP)、血管活性肠肽(VIP)、5-羟色胺(5-HT)、胆囊收缩素(CCK)水平,以及中医证候总积分、生活质量、不良反应。结果治疗前,观察组与对照组CGRP、VIP、5-HT、CCK水平,中医证候总积分,IBS生活质量量表(IBS-QOL)评分比较,差异无统计学意义(P>0.05)。治疗后,观察组总有效率(94.87%)高于对照组(79.92%),CGRP、VIP、5-HT、CCK水平及中医证候总积分均低于对照组,IBS-QOL评分高于观察组,差异均有统计学意义(P<0.05)。两组均未见明显不良反应。结论匹维溴铵治疗基础上联合参苓白术散加减治疗IBS-D脾虚湿盛证患者效果确切,且具有良好的安全性,值得临床推广应用。 展开更多
关键词 腹泻型肠易激综合征 脾虚湿盛证 参苓白术散加减 胃肠激素 生活质量 安全性
下载PDF
半夏和胃颗粒联合益生菌治疗腹泻型肠易激综合征临床观察
16
作者 刘德清 张丽红 +1 位作者 苗洁 李多 《河北北方学院学报(自然科学版)》 2024年第8期5-7,11,共4页
目的 探讨半夏和胃颗粒联合益生菌治疗腹泻型肠易激综合征(irritable bowel syndrome, IBS)的临床疗效和对血清胃肠激素水平的影响。方法 73例腹泻型IBS患者随机分为对照组35例及观察组38例,对照组给予复方嗜酸乳杆菌片口服,观察组在对... 目的 探讨半夏和胃颗粒联合益生菌治疗腹泻型肠易激综合征(irritable bowel syndrome, IBS)的临床疗效和对血清胃肠激素水平的影响。方法 73例腹泻型IBS患者随机分为对照组35例及观察组38例,对照组给予复方嗜酸乳杆菌片口服,观察组在对照组治疗的基础上加用半夏和胃颗粒,均治疗28 d。比较治疗前后2组患者血清胃动素(motilin, MTL)及血管活性肠肽(vasoactive intestinal peptide, VIP)水平变化及临床疗效。结果 观察组治疗总有效率高于对照组(P<0.05)。治疗前2组患者血清MTL、VIP水平比较差异无统计学意义;治疗后2组患者血清MTL水平均较治疗前下降,VIP水平均较治疗前上升(P<0.05),观察组改善优于对照组(P<0.05)。结论 半夏和胃颗粒联合益生菌治疗腹泻型IBS可明显减轻患者临床症状,调节胃肠激素水平且不增加不良反应,值得临床参考应用。 展开更多
关键词 半夏和胃颗粒 益生菌 腹泻型肠易激综合征 胃动素 血管活性肠肽
下载PDF
基于近红外光谱与协同表示方法的贻贝毒素快速检测
17
作者 乔付 刘忠艳 刘瑶 《食品与发酵工业》 CAS CSCD 北大核心 2024年第12期292-298,共7页
该文应用近红外光谱和类别相关残差约束的非负表示分类(class-specific residual constraint non-negative representation base classification,CRNRC)方法快速识别被毒素污染的贻贝。受腹泻贝类毒素(diarrheal shellfish toxins,DST)... 该文应用近红外光谱和类别相关残差约束的非负表示分类(class-specific residual constraint non-negative representation base classification,CRNRC)方法快速识别被毒素污染的贻贝。受腹泻贝类毒素(diarrheal shellfish toxins,DST)污染的贻贝,其组织变化可通过近红外光谱曲线反映出来,可利用CRNRC模型对健康贻贝和受DST污染的贻贝进行分类。在CRNRC模型中引入类相关残差项和协同表示,将编码与分类联系起来。研究了CRNRC的编码向量,通过实验确定CRNRC模型的最优参数。实验结果表明,CRNRC模型在平均准确率、F-measure、1-specificity等评价指标上均优于协同表示和非负表示分类模型;近红外光谱与CRNRC相结合,能有效地鉴别被DST污染的贻贝,该检测方法具有智能、无损、准确、不需要化学试剂等优点。可将CRNRC模型的近红外光谱检测方法扩展到其他海鲜产品的检测(如检测海鲜产品核污染程度),以确保人类摄入健康的海鲜产品。 展开更多
关键词 腹泻贝类毒素 近红外光谱 贻贝 类别相关残差约束 非负表示
下载PDF
乙酸灌肠联合束缚夹尾应激诱导肝郁脾虚型腹泻型肠易激综合征大鼠模型的制备
18
作者 赖碧玉 洪梦颖 +8 位作者 李兴 何永嘉 陈瑶 李新伍 石佳 田子寒 李丹 聂晶 佘畅 《中国实验动物学报》 CAS CSCD 北大核心 2024年第3期317-328,共12页
目的 建立理想的大鼠肝郁脾虚型腹泻型肠易激综合征(diarrhea predominant irritable bowel syndrome, IBS-D)的造模方法,为IBS-D伴焦虑抑郁状态的临床研究提供动物模型基础。方法 本研究共用60只大鼠:(1)首先将20只大鼠随机分为空白组... 目的 建立理想的大鼠肝郁脾虚型腹泻型肠易激综合征(diarrhea predominant irritable bowel syndrome, IBS-D)的造模方法,为IBS-D伴焦虑抑郁状态的临床研究提供动物模型基础。方法 本研究共用60只大鼠:(1)首先将20只大鼠随机分为空白组、3%乙酸灌肠组、4%乙酸灌肠组、5%乙酸灌肠组,造模及观察期结束后,通过腹泻相关指数、结肠病理组织学等观察不同造模浓度引起的腹泻状态及结肠损伤程度。(2)评估出较优造模浓度后,将另外40只大鼠随机分为对照组(a组)、单纯乙酸灌肠组(b组)、乙酸+束缚组(c组)、乙酸+束缚+夹尾组(d组),分别予以不同干预,共干预8 d。干预结束后对大鼠一般情况、腹泻相关指数、旷场实验(open-field test, OFT)评分、结肠病理组织学等指标进行评价。结果 (1)与空白组比较,4%乙酸灌肠组干预后第1~3天粪便性状评分升高(P<0.001),干预后第4~7天粪便性状评分逐渐降低,1周后,与空白组相比,粪便性状评分无显著性差异(P>0.05),体重相对较低(P<0.01),粪便含水量升高(P<0.001);与空白组相比,5%乙酸灌肠组体重较低(P<0.001),粪便性状评分、粪便含水量、腹泻指数升高(P<0.01);3%乙酸灌肠组与空白组相比,无显著性差异(P>0.05)。结肠病理组织显示,与空白组相比,4%乙酸灌肠组黏膜结构完整,有少量炎症细胞浸润,病理组织评分无显著性差异(P>0.05),5%乙酸灌肠组有中量-大量炎症细胞浸润,病理组织评分升高(P<0.01)。(2)与a组比较,b组体重较低(P<0.001),粪便性状评分、粪便含水量、腹泻指数升高(P<0.01),与a组及b组比较,c组和d组,体重较低(P<0.001),粪便性状评分、粪便含水量、腹泻指数升高(P<0.01),结肠运转时间减少(P<0.01);与c组相比,d组粪便含水量较高(P<0.001)。在OFT评分方面,与a组及b组相比,c组及d组OFT评分在总距离、站立次数、直立次数均减少(P<0.05);与c组相比,d组在OFT评分总距离、站立次数、直立次数均减少(P<0.05)。结肠病理组织显示,4组黏膜结构均完整,有不同程度的炎症细胞浸润,病理组织评分上,与a组及b组相比,c组和d组较高(P<0.05)。结论 4%乙酸浓度为IBS-D造模适宜浓度,叠加束缚后,能更好地模拟IBS-D腹泻、内脏高敏感特征性状态,叠加夹尾后能成功制备出肝郁脾虚型IBS-D模型。 展开更多
关键词 腹泻型肠易激综合征 4%乙酸灌肠 慢性束缚 夹尾应激 造模
下载PDF
基于数据挖掘某院中医药治疗腹泻型肠易激综合征的用药规律
19
作者 吴燕 黎豫川 +1 位作者 张远哲 徐献梅 《贵州医科大学学报》 CAS 2024年第1期121-125,133,共6页
目的 采用数据挖掘方法探讨医院中医药治疗脾虚腹泻型肠易激综合征(IBS-D)的组方用药规律。方法 检索2016—2022年贵州某医院中医药治疗脾虚型IBS-D处方,采用Microsoft Excel 2007建立中药处方信息表,利用SPSS 23.0与SPSS Modeler18.0... 目的 采用数据挖掘方法探讨医院中医药治疗脾虚腹泻型肠易激综合征(IBS-D)的组方用药规律。方法 检索2016—2022年贵州某医院中医药治疗脾虚型IBS-D处方,采用Microsoft Excel 2007建立中药处方信息表,利用SPSS 23.0与SPSS Modeler18.0软件进行性味归经、功效、频数、关联规则、聚类分析等以挖掘医院中医药治疗脾虚型IBS-D的用药规律。结果 共纳入中药处方502首,处方中药味多见甘味,药性以温、平性为主,多归于脾、胃经,治疗药物以补虚药、行气药为主,药物使用频次较高的中药有白术、木香、陈皮等;治疗常用药对组合有白术-木香、白术-陈皮、木香-陈皮等,聚类分析得出3类处方,主要功效益气健脾、行气化痰、渗湿止泻等。结论 医院中医药治疗脾虚型IBS-D组方规律以益气健脾、行气化痰、渗湿止泻为主要治法,临床常用香砂六君子汤、参苓白术散等加减方辨证治疗。 展开更多
关键词 脾虚腹泻型肠易激综合征 中医药 数据挖掘 关联规则 聚类分析 用药规律
下载PDF
基于网络药理学和分子对接技术的理中汤治疗腹泻型肠易激综合征的作用机制
20
作者 贾丽 《宁夏医科大学学报》 2024年第2期182-189,共8页
目的通过网络药理学和分子对接技术探讨理中汤治疗腹泻型肠易激综合征(IBS-D)的潜在分子机制。方法通过TCMSP数据库获取理中汤主要化学成分及其作用靶标,从GeneCards数据库获取IBS-D疾病靶标,采用R软件处理疾病症与理中汤有效成分靶标,... 目的通过网络药理学和分子对接技术探讨理中汤治疗腹泻型肠易激综合征(IBS-D)的潜在分子机制。方法通过TCMSP数据库获取理中汤主要化学成分及其作用靶标,从GeneCards数据库获取IBS-D疾病靶标,采用R软件处理疾病症与理中汤有效成分靶标,绘制韦恩图。通过Cytoscape 3.7.1软件联合STRING数据库构建蛋白互作(PPI)网络,对交集靶标进行GO和KEGG富集分析,使用Vina软件对核心靶标及有效成分进用分子对接验证。结果筛选得出药物疾病共同靶点155个,通过PPI网络的拓扑分析出度值前五的靶蛋白c-Jun氨基末端激酶(JUN)、信号传导及转录激活蛋白3(STAT3)、雌激素受体1(ESR1)、蛋白激酶1(AKT1)和白细胞介素(IL)-1β;GO和KEGG通路富集分析表明,理中汤可能作用于IL-17、癌症相关、糖尿病并发症中AGE-RAGE、动脉粥样硬化、TNF等相关信号通路,可通过减少病理损伤、炎症和氧化应激反应,从而减轻IBS-D。分子对接显示,活性化合物与筛选出的靶标之间具有良好的结合能力。结论理中汤通过多成分、多靶点、多途径的相互作用,以及调节炎症反应、氧化应激等主要病理环节治疗IBS-D。 展开更多
关键词 网络药理学 分子对接 腹泻型肠易激综合征 理中汤
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部